ClinicalTrials.Veeva

Menu

Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?

Vanderbilt University logo

Vanderbilt University

Status

Terminated

Conditions

Hemostasis
Bladder Cancer

Treatments

Device: Stapling device during radical cystectomy
Device: Ligasure tissue sealing device

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.

Enrollment

80 patients

Sex

All

Ages

19 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Muscle invasive bladder cancer
  • Male/Female gender

Exclusion Criteria:

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Stapling device
Active Comparator group
Description:
Efficacy of stapling device during radical cystectomy
Treatment:
Device: Stapling device during radical cystectomy
Ligasure Device
Active Comparator group
Description:
Efficacy of ligasure tissue sealing device during radical cystectomy
Treatment:
Device: Ligasure tissue sealing device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems